New England Journal of Medicine Publishes New Data for Genentech's Gazyva Which Shows Superiority Over Standard Therapy in People With Active Lupus Nephritis

7 months ago 31
Read Entire Article
  1. Homepage
  2. Finance
  3. New England Journal of Medicine Publishes New Data for Genentech's Gazyva Which Shows Superiority Over Standard Therapy in People With Active Lupus Nephritis

Related

OpenAI generates $4.3 billion in revenue in first half of 2025, the Information reports (Sept 29)

OpenAI generates $4.3 billion in revenue in first half of 20...

40 minutes ago 1
Form 13G CAMPBELL'S Co For: 1 October

Form 13G CAMPBELL'S Co For: 1 October

40 minutes ago 1
Monolithic Power Systems EVP Blegen sells $2.74 million in shares

Monolithic Power Systems EVP Blegen sells $2.74 million in s...

40 minutes ago 1

Trending

1. teresa giudice
2. wes moore
3. survivor 49
4. elizabeth warren
5. love island games season 2
6. colorado avalanche
7. aurora borealis geomagnetic storm
8. freddie freeman
9. vancouver fc vs vancouver
10. ohtani

Popular

College football by the odds: Vegas picks and preview of Ohio State vs. Notre Dame

College football by the odds: Vegas picks and preview of Ohi...

8 months ago 578
What is Tren de Aragua, the Venezuelan gang targeted by Trump?

What is Tren de Aragua, the Venezuelan gang targeted by Trum...

6 months ago 320
What to do in Las Vegas this week: January 2-8

What to do in Las Vegas this week: January 2-8

8 months ago 258
Taiwan slightly cuts 2025 GDP growth outlook amid Trump tariffs concern

Taiwan slightly cuts 2025 GDP growth outlook amid Trump tari...

7 months ago 243
Australian whose blood saved 2.4 million babies dies

Australian whose blood saved 2.4 million babies dies

6 months ago 218
English (US) English (US) ·
About Us · Contact Us · Terms & Conditions ·

© Sincity Press 2025. All rights are reserved